Cholangiocarcinoma
Showing 26 - 50 of 287
Bile Duct Cancer, Cholangiocarcinoma, Cholangiocarcinoma Non-resectable Trial in Boston (Gemcitabine, Cisplatin, Durvalumab)
Not yet recruiting
- Bile Duct Cancer
- +4 more
- Gemcitabine
- +3 more
-
Boston, MassachusettsBeth Israel Deaconess Medical Center
Jan 23, 2023
Metastatic Colorectal Cancer (Mcrc), Intrahepatic Cholangiocarcinoma (Icc), Colorectal Cancer Trial run by the National Cancer
Recruiting
- Metastatic Colorectal Cancer (Mcrc)
- +7 more
- Floxuridine
- +8 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 23, 2023
Cholangiocarcinoma, Gall Bladder Carcinoma Trial in Worldwide (Gemcitabine, Cisplatin, Capecitabine)
Active, not recruiting
- Cholangiocarcinoma
- Gall Bladder Carcinoma
- Gemcitabine
- +2 more
-
Bankstown, New South Wales, Australia
- +66 more
Jan 22, 2023
l Science Network of Precision-based Immunotherapy for Primary
Recruiting
- Hepatocellular Carcinoma
- +2 more
-
La Jolla, California
- +6 more
Jan 24, 2023
Advanced Cancer, Anal Carcinoma, Anal Cancer Trial in Worldwide (pembrolizumab)
Recruiting
- Advanced Cancer
- +24 more
- pembrolizumab
-
Los Angeles, California
- +21 more
Jan 18, 2023
Minimal Residual Disease, KRAS G12D, KRAS G12R Trial in United States (ELI-002 2P)
Recruiting
- Minimal Residual Disease
- +11 more
- ELI-002 2P
-
Duarte, California
- +10 more
Jan 18, 2023
Hilar Cholangiocarcinoma, Intrahepatic Cholangiocarcinoma, Common Bile Duct Tumors Trial in Rotterdam (Endoscopic Ultrasound
Recruiting
- Hilar Cholangiocarcinoma
- +4 more
- Endoscopic Ultrasound registration
-
Rotterdam, Zuid-Holland, NetherlandsErasmus University Medical Center
Jan 11, 2023
Biliary Cell-derived Organoids From Bile of PSC and Non-PSC
Recruiting
- Primary Sclerosing Cholangitis
- +2 more
-
Rochester, MinnesotaMayo Clinic in Rochester
Jan 9, 2023
Cholangiocarcinoma, Stage III Gallbladder Cancer AJCC v7, Stage IIIA Gallbladder Cancer AJCC v7 Trial in Scottsdale, Rochester
Active, not recruiting
- Cholangiocarcinoma
- +6 more
- Laboratory Biomarker Analysis
- Trifluridine/Tipiracil Hydrochloride Combination Agent TAS-102
-
Scottsdale, Arizona
- +1 more
Jan 4, 2023
Cholangiocarcinoma Trial in Düsseldorf (Combination of Lonsurf® and Irinotecan)
Recruiting
- Cholangiocarcinoma
- Combination of Lonsurf® and Irinotecan
-
Düsseldorf, NRW, GermanyKlinik für Gastroenterologie, Hepatologie und Infektiologie
Dec 22, 2022
Hepatocellular Carcinoma, Liver Metastases, Cholangiocarcinoma Trial in United States (STP705)
Active, not recruiting
- Hepatocellular Carcinoma
- +2 more
-
Scottsdale, Arizona
- +4 more
Dec 13, 2022
Gastrointestinal Cancers, Cholangiocarcinoma, Gastric Cancer Trial ([18F]FAPI-74 PET/CT)
Not yet recruiting
- Gastrointestinal Cancers
- +5 more
- [18F]FAPI-74 PET/CT
- (no location specified)
Nov 29, 2022
Drug Sensitivity of Patient-Derived Organoid Model From
Recruiting
- Cholangiocarcinoma
- No interventions.
-
Guangzhou, Guangdong, ChinaSun Yat-sen Memorial Hospital, Sun Yat-sen University
Nov 29, 2022
Advanced or Metastatic Solid Tumors, Lung Cancer, Breast Cancer Trial in United States (NC318)
Active, not recruiting
- Advanced or Metastatic Solid Tumors
- +8 more
-
Los Angeles, California
- +5 more
Nov 29, 2022
Cholangiocarcinoma, Bile Duct Cancer Trial in Toronto (Trifluridine/Tipiracil)
Terminated
- Cholangiocarcinoma
- Bile Duct Cancer
-
Toronto, Ontario, CanadaSunnybrook Health Sciences Centre
Nov 28, 2022
Melanoma, Breast Carcinoma, Hepatocellular Carcinoma Trial in United States (XmAb20717)
Completed
- Melanoma
- +27 more
- XmAb20717
-
Los Angeles, California
- +16 more
Nov 29, 2022
Cholangiocarcinoma Trial in Ann Arbor (KSP/QRH dimer)
Terminated
- Cholangiocarcinoma
- KSP/QRH dimer
-
Ann Arbor, MichiganMichigan Medicine
Nov 17, 2022
Cholangiocarcinoma Trial (Hematoporphyrin Injection actived by photodynamic therapy combined with Sonodynamic Therapy)
Not yet recruiting
- Cholangiocarcinoma
- Hematoporphyrin Injection actived by photodynamic therapy combined with Sonodynamic Therapy
- (no location specified)
Nov 10, 2022
Prospective Evaluation of Biliary Tissue Sampling With ERCP
Enrolling by invitation
- Cholangiopancreatography, Endoscopic Retrograde
- +3 more
-
Rochester, MinnesotaMayo Clinic in Rochester
Nov 7, 2022
Pancreatic Cancer, Cholangiocarcinoma, Gallbladder Cancer Trial in Seoul (cell free DNA in blood and urine,
Recruiting
- Pancreatic Cancer
- +2 more
- cell free DNA in blood and urine, metabolite/microbiome in urine and stool
-
Seoul, Korea, Republic of
- +1 more
Nov 2, 2022